atovaquone has been researched along with Parasitemia in 49 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (14.29) | 18.2507 |
2000's | 18 (36.73) | 29.6817 |
2010's | 20 (40.82) | 24.3611 |
2020's | 4 (8.16) | 2.80 |
Authors | Studies |
---|---|
Clark, JA; Connelly, MC; El Mazouni, F; Furimsky, A; Gow, J; Guiguemde, WA; Guy, RK; Iyer, L; Kyle, DE; Min, J; Mirsalis, J; Parman, T; Phillips, MA; Pradhan, A; Zhang, Y; Zhu, F | 1 |
Bathurst, I; Burrows, JN; Charman, SA; Cross, RM; Flanigan, DL; Fronczek, FR; Guida, WC; Kyle, DE; LaCrue, AN; Maignan, JR; Manetsch, R; Monastyrskyi, A; Mutka, TS; Sáenz, FE; Shackleford, DM; White, KL; Wojtas, L | 1 |
Azas, N; Basmaciyan, L; Cohen, A; Crozet, MD; Dallemagne, P; Deharo, E; Dumètre, A; Hutter, S; Laget, M; Lancelot, JC; Lesnard, A; Lorthiois, A; Mazier, D; Paloque, L; Rathelot, P; Rault, S; Sibley, CH; Suzanne, P; Valentin, A; Vanelle, P; Verhaeghe, P | 1 |
Jacobs, JW; Siddon, AJ | 1 |
Ivancich, M; Lutwick, L; Shweta, FNU | 1 |
Handel, AS; Hellman, H; Hymes, SR | 1 |
Chenet, SM; Fernandez, J; Jercic, MI; Lucchi, NW; Oyarce, A; Tapia-Limonchi, R; Tejedo, JR; Udhayakumar, V; Weitzel, T | 1 |
Chiu, JE; Dodean, R; Doggett, JS; Frueh, L; Gihaz, S; Kumar, M; Mamoun, CB; Nilsen, AC; Pal, AC; Pou, S; Renard, I; Riscoe, MK; Singh, P; Thekkiniath, J; Vydyam, P; Winter, RW | 1 |
Almela, MJ; Angulo-Barturen, Í; Bamborough, P; Burrows, J; Calderón, F; Cammack, N; Castañeda, P; Chaparro, MJ; Coterón, JM; Crespo, B; de Cozar, C; de la Rosa, JC; de Mercado, J; Díaz, B; Drewes, G; Fernández, E; Ferrer-Bazaga, S; Fraile, MT; Gamo, FJ; Ghidelli-Disse, S; Gómez, R; Haselden, J; Huss, S; Jiménez Díaz, MB; Lafuente-Monasterio, MJ; León, ML; Macdonald, SJF; Martín Hernando, JI; Martínez-Martínez, MS; Prats, S; Puente, M; Rodríguez, A; Rueda, L; Sandoval, E; Selenski, C; Vidal, J; Willis, P; Wilson, DM; Witty, M | 1 |
Charunwatthana, P; Chotivanich, K; Dondorp, AM; Färnert, A; Herder, C; Holmer, E; Kiwuwa, MS; Kristensen, J; Lee, SJ; Leitgeb, AM; Lindgren, M; Moll, K; Rueangveerayut, R; Sila, P; Silamut, K; Tarning, J; Uthaisin, C; Wahlgren, M | 1 |
Berman, J; DiTusa, C; Gettayacamin, M; Im-erbsin, R; Kozar, MP; Ohrt, C; Pybus, B; Sousa, J; Tungtaeng, A | 1 |
Hikasa, Y; Iguchi, A; Matsuu, A; Shiranaga, N | 1 |
Akala, HM; Auschwitz, JM; Cheruiyot, AC; Gaona, HW; Hickman, MR; Johnson, JD; Kamau, E; Lee, PJ; Leed, SE; Murthy, T; Okello, CO; Talwar, M; Yeda, RA | 1 |
Bouchaud, O; Bruneel, F; Camus, C; Caumes, E; Choquet, C; Corne, P; Durand, R; Gibot, S; Girard, PM; Houze, S; Huisse, MG; Kalloumeh, A; Le Bras, J; Matheron, S; Megarbane, B; Mira, JP; Peytel, E; Roy, C; Simon, F; Tubach, F; Villers, D; Wolff, M | 1 |
Forquer, IP; Kelly, JX; Li, Y; Morrisey, JM; Nilsen, A; Pou, S; Riscoe, MK; Smilkstein, MJ; Stickles, AM; Vaidya, AB; Winter, RW | 1 |
Bartolomé, A; Checa, R; Gálvez, R; González-Fraga, JL; Marino, V; Miró, G; Montoya, A; Ortega, N | 1 |
Benoit-Vical, F; Berry, A; Garcia-Alvarez, MC; Nicolau, ML; Olagnier, D; Soh, PN; Witkowski, B | 1 |
Burke, M; Chiodini, PL; Fivelman, QL; Klein, JL; Laundy, M; Pasvol, G; Price, N; Sutherland, CJ | 1 |
Bensch, S; Bolshakov, CV; Krizanauskiene, A; Palinauskas, V; Valkiūnas, G | 1 |
Boggild, AK; Kain, KC; Katz, K; Krudsood, S; Liles, WC; Looareesuwan, S; Patel, SN; Serghides, L; Tangpukdee, N; Wilairatana, P | 1 |
Aguero-Rosenfeld, M; Joshi, S; Krause, PJ; Mittleman, A; Nelson, J; Neuhaus, E; Nowakowski, J; Prasad, A; Topal, J; Wormser, GP | 1 |
Forestier, E; Labe, A; Lecomte, C; Raffenot, D; Rogeaux, O | 1 |
Lubin, AS; Miller, KB; Snydman, DR | 1 |
Bautista, JM; Diez, A; García-Granados, A; Marín-García, P; Moneriz, C; Puyet, A | 1 |
Ganesan, SM; Ke, H; Mather, MW; Morrisey, JM; Painter, HJ; Vaidya, AB | 1 |
Clemens, EG; Deye, GA; Dumler, JS; Fracisco, S; Macareo, L; Magill, AJ; Miller, L; Miller, RS; Murphy, J; Salas, CJ; Smith, BL; Sousa, JC; Tosh, D | 1 |
Basco, LK; Delmont, J; Moyou-Somo, R; Ngane Foumane, V; Sayang, C; Soula, G; Tahar, R | 1 |
Borrmann, S; Erkens, MA; Graumans, W; Heinrichs, MJ; Hermsen, CC; Hoffman, SL; Luty, AJ; Nganou-Makamdop, K; Roestenberg, M; Rozier, YP; Sauerwein, RW; Scholzen, A; Siebelink-Stoter, R; Sim, BK; Teelen, K; Teirlinck, AC; van de Vegte-Bolmer, M; van Gemert, GJ; van Lieshout, L; Visser, LG; Vos, MW | 1 |
Binh, TQ; De Vries, PJ; Giao, PT; Hung, LQ; Kager, PA; Nam, NV | 1 |
Binh, TQ; de Vries, PJ; Giao, PT; Hung, le Q; Kager, PA; Nam, NV | 1 |
Ashley, EA; Barends, M; Cho, T; Hutagalung, R; Looareesuwan, S; McGready, R; Moo, E; Nosten, F; White, NJ | 1 |
Berzins, K; Grandien, A; Hagstedt, M; Nyakeriga, AM; Perlmann, H; Perlmann, P; Troye-Blomberg, M; Zhivotovsky, B | 1 |
Bennett, S; Fielding, K; Greenwood, B; Malunga, P; Mulenga, M; Shulman, C; Thuma, P | 1 |
Alloueche, A; Bennett, S; Fielding, K; Greenwood, BM; Malunga, F; Mulenga, M; Shulman, C; Thuma, PE | 1 |
Chollet, J; Santo-Tomas, J; Scheurer, C; Snyder, C; Wittlin, S | 1 |
Abreu-Acosta, N; Foronda, P; Lorenzo-Morales, J; Orós, J; Ortega-Rivas, A; Santana-Morales, MA; Valladares, B | 1 |
Irwin, PJ; Jardine, J; Jefferies, R; Robertson, ID; Ryan, UM | 1 |
Burgner, D; Cherian, S | 1 |
Kita, K; Marzuki, S; Matsuoka, H; Siregar, JE; Syafruddin, D | 1 |
Ballou, WR; Heppner, DG; Lievens, M; Ogutu, B; Polhemus, ME; Remich, S; Waitumbi, J | 1 |
Kain, KC; Le Saux, N; McCarthy, AE; Rose, GW; Suh, KN | 1 |
Hughes, WT; Oz, HS | 1 |
Lederman, J; Rosenbaum, GS; Tanowitz, HB; Weiss, LM; Wittner, M | 1 |
Gray, JS; Pudney, M | 1 |
Aleman, GM; Gordon, DM; Klotz, FW; Oloo, AJ; Sadie, D; Scott, TR; Shanks, GD | 1 |
Aumjaud, Y; Derouin, F; Fessi, H; Sordet, F | 1 |
Barditch-Crovo, P; Kumar, N; Ranasinha, CD; Shapiro, TA | 1 |
Chisdaka, N; Mulenga, M; Roskell, NS; Scott, TR; Sukwa, TY | 1 |
Adagu, IS; Butcher, GA; Fivelman, QL; Pasvol, G; Warhurst, DC | 1 |
12 trial(s) available for atovaquone and Parasitemia
Article | Year |
---|---|
Inhibition of merozoite invasion and transient de-sequestration by sevuparin in humans with Plasmodium falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antimalarials; Area Under Curve; Atovaquone; Binding, Competitive; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Erythrocytes; Female; Heparin; Heparitin Sulfate; Humans; Infusions, Intravenous; Malaria, Falciparum; Male; Merozoites; Middle Aged; Parasite Load; Parasitemia; Plasmodium falciparum; Proguanil; Severity of Illness Index | 2017 |
Use of peroxisome proliferator-activated receptor gamma agonists as adjunctive treatment for Plasmodium falciparum malaria: a randomized, double-blind, placebo-controlled trial.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Animals; Antimalarials; Atovaquone; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Immunity, Innate; Inflammation; Inflammation Mediators; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Plasmodium falciparum; PPAR gamma; Proguanil; Rosiglitazone; Thailand; Thiazolidinediones; Time Factors; Treatment Outcome; Young Adult | 2009 |
Prolonged protection provided by a single dose of atovaquone-proguanil for the chemoprophylaxis of Plasmodium falciparum malaria in a human challenge model.
Topics: Adult; Antimalarials; Area Under Curve; Atovaquone; Chemoprevention; Cohort Studies; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Placebos; Plasmodium falciparum; Proguanil; Sporozoites | 2012 |
NF135.C10: a new Plasmodium falciparum clone for controlled human malaria infections.
Topics: Adolescent; Adult; Animals; Anopheles; Antimalarials; Atovaquone; Genotype; Humans; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Proguanil; Treatment Outcome; Young Adult | 2013 |
CV8, a new combination of dihydroartemisinin, piperaquine, trimethoprim and primaquine, compared with atovaquone-proguanil against falciparum malaria in Vietnam.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemisinins; Atovaquone; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Naphthoquinones; Parasitemia; Plasmodium falciparum; Primaquine; Proguanil; Quinolines; Sesquiterpenes; Treatment Outcome; Trimethoprim; Vietnam | 2004 |
A randomized comparison of artesunate-atovaquone-proguanil versus quinine in treatment for uncomplicated falciparum malaria during pregnancy.
Topics: Adolescent; Adult; Anemia; Animals; Antimalarials; Artemisinins; Artesunate; Atovaquone; Female; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Naphthoquinones; Parasitemia; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Proguanil; Quinine; Sesquiterpenes; Thailand | 2005 |
Folic acid treatment of Zambian children with moderate to severe malaria anemia.
Topics: Anemia; Animals; Antimalarials; Atovaquone; Child; Child, Preschool; Drug Combinations; Folic Acid; Hematinics; Humans; Infant; Malaria, Falciparum; Naphthoquinones; Parasitemia; Population Density; Proguanil; Pyrimethamine; Sulfadoxine; Treatment Failure; Zambia | 2006 |
A randomised, double-blind, placebo-controlled trial of atovaquone-proguanil vs. sulphadoxine-pyrimethamine in the treatment of malarial anaemia in Zambian children.
Topics: Anemia; Antimalarials; Atovaquone; Child; Child, Preschool; Double-Blind Method; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Prevalence; Proguanil; Pyrimethamine; Sulfadoxine; Time Factors; Treatment Failure; Zambia | 2006 |
Malaria treatment with atovaquone-proguanil in malaria-immune adults: implications for malaria intervention trials and for pre-exposure prophylaxis of malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Atovaquone; Chemoprevention; Humans; Kaplan-Meier Estimate; Kenya; Malaria Vaccines; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Proguanil; Time Factors | 2008 |
Efficacy and safety of atovaquone/proguanil as suppressive prophylaxis for Plasmodium falciparum malaria.
Topics: Adolescent; Adult; Aged; Antimalarials; Atovaquone; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Endemic Diseases; Female; Humans; Kenya; Malaria, Falciparum; Male; Middle Aged; Naphthoquinones; Parasitemia; Proguanil; Treatment Outcome | 1998 |
Prophylactic activity of atovaquone against Plasmodium falciparum in humans.
Topics: Adolescent; Adult; Animals; Anopheles; Antimalarials; Atovaquone; Double-Blind Method; Humans; Insect Bites and Stings; Malaria, Falciparum; Middle Aged; Naphthoquinones; Parasitemia; Plasmodium falciparum; Polymerase Chain Reaction | 1999 |
A randomized, double-blind, placebo-controlled field trial to determine the efficacy and safety of Malarone (atovaquone/proguanil) for the prophylaxis of malaria in Zambia.
Topics: Adolescent; Adult; Animals; Antimalarials; Atovaquone; Double-Blind Method; Drug Combinations; Humans; Malaria, Falciparum; Male; Middle Aged; Naphthoquinones; Parasitemia; Plasmodium falciparum; Proguanil; Zambia | 1999 |
37 other study(ies) available for atovaquone and Parasitemia
Article | Year |
---|---|
Lead optimization of 3-carboxyl-4(1H)-quinolones to deliver orally bioavailable antimalarials.
Topics: Administration, Oral; Animals; Antimalarials; Biological Availability; Female; Hep G2 Cells; Humans; Malaria, Falciparum; Mice; Mice, Inbred ICR; Nuclear Magnetic Resonance, Biomolecular; Parasitemia; Plasmodium falciparum; Quinolines; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Structure-Activity Relationship | 2012 |
Orally bioavailable 6-chloro-7-methoxy-4(1H)-quinolones efficacious against multiple stages of Plasmodium.
Topics: Animals; Antimalarials; Humans; Inhibitory Concentration 50; Malaria; Mice; Microsomes, Liver; Parasitemia; Plasmodium; Plasmodium berghei; Quinolones; Structure-Activity Relationship | 2014 |
Discovery of new thienopyrimidinone derivatives displaying antimalarial properties toward both erythrocytic and hepatic stages of Plasmodium.
Topics: Animals; Antimalarials; Cell Proliferation; CHO Cells; Cricetinae; Cricetulus; Drug Discovery; Erythrocytes; Hep G2 Cells; Humans; Liver; Malaria; Male; Mice; Parasitemia; Plasmodium falciparum; Pyrimidines; Structure-Activity Relationship; Trophozoites | 2015 |
Concurrent COVID-19 and babesiosis in an older, splenectomized patient.
Topics: Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Atovaquone; Azithromycin; Babesiosis; BNT162 Vaccine; COVID-19; COVID-19 Drug Treatment; Fever; Humans; Leukemia, Myeloid, Acute; Male; Parasitemia; Remission Induction; SARS-CoV-2; Splenectomy | 2021 |
Trust the Process: Prolonged Babesia Parasitemia in an Elderly Man with Asplenia from the American Midwest.
Topics: Aged; Aged, 80 and over; Atovaquone; Azithromycin; Babesia; Babesiosis; Humans; Male; Parasitemia; Trust; United States | 2022 |
Two Neonates With Postnatally Acquired Tickborne Infections.
Topics: Animals; Anti-Bacterial Agents; Antiprotozoal Agents; Atovaquone; Azithromycin; Babesiosis; Ceftriaxone; Erythema Chronicum Migrans; Exanthema; Female; Humans; Infant, Newborn; Parasitemia; Tick Bites | 2019 |
Atovaquone/Proguanil Resistance in an Imported Malaria Case in Chile.
Topics: Adult; Antimalarials; Artesunate; Atovaquone; Chile; Cytochromes b; Drug Combinations; Drug Resistance; Female; Gene Expression; Humans; Malaria, Falciparum; Male; Mefloquine; Mutation; Nigeria; Parasitemia; Plasmodium falciparum; Proguanil; Protozoan Proteins; Recurrence; Tetrahydrofolate Dehydrogenase; Travel | 2021 |
Effective Therapy Targeting Cytochrome
Topics: Animals; Atovaquone; Babesia; Babesiosis; Cytochromes; Mice; Parasitemia | 2021 |
The Discovery of Novel Antimalarial Aminoxadiazoles as a Promising Nonendoperoxide Scaffold.
Topics: 2,2'-Dipyridyl; Animals; Antimalarials; Atovaquone; Chloroquine; Drug Design; Female; Humans; Hydrazines; Mice; Mutagenicity Tests; Mutagens; Oxadiazoles; Parasitemia; Plasmodium falciparum; Pyrimethamine; Structure-Activity Relationship | 2017 |
Causal prophylactic efficacy of primaquine, tafenoquine, and atovaquone-proguanil against Plasmodium cynomolgi in a rhesus monkey model.
Topics: Aminoquinolines; Animals; Antimalarials; Atovaquone; Disease Models, Animal; Drug Combinations; Macaca mulatta; Malaria; Parasitemia; Plasmodium cynomolgi; Primaquine; Proguanil | 2014 |
Efficacy of Malarone(®) in dogs naturally infected with Babesia gibsoni.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Atovaquone; Babesia; Babesiosis; Bilirubin; Blood Cell Count; Blood Urea Nitrogen; Creatinine; DNA, Protozoan; Dog Diseases; Dogs; Doxycycline; Drug Combinations; Drug Therapy, Combination; Female; Globulins; Male; Parasitemia; Polymerase Chain Reaction; Proguanil; Serum Albumin | 2014 |
Assessment of the Worldwide Antimalarial Resistance Network Standardized Procedure for In Vitro Malaria Drug Sensitivity Testing Using SYBR Green Assay for Field Samples with Various Initial Parasitemia Levels.
Topics: Antimalarials; Artemisinins; Atovaquone; Benzothiazoles; Biological Assay; Chloroquine; Diamines; DNA, Protozoan; Drug Resistance; Erythrocytes; Fluorescent Dyes; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Organic Chemicals; Parasitemia; Plasmodium falciparum; Public Health Surveillance; Quinolines; Reproducibility of Results; Sensitivity and Specificity | 2016 |
Imported falciparum malaria in adults: host- and parasite-related factors associated with severity. The French prospective multicenter PALUREA cohort study.
Topics: Adult; Analysis of Variance; Animals; Antigens, Protozoan; Antimalarials; Atovaquone; Biomarkers; C-Reactive Protein; Calcitonin; Drug Combinations; Female; France; Host-Parasite Interactions; Humans; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Plasmodium falciparum; Proguanil; Prospective Studies; Protozoan Proteins; Quinine; Severity of Illness Index | 2016 |
Atovaquone and ELQ-300 Combination Therapy as a Novel Dual-Site Cytochrome bc1 Inhibition Strategy for Malaria.
Topics: Animals; Antimalarials; Atovaquone; Drug Combinations; Drug Therapy, Combination; Electron Transport Complex III; Female; Malaria, Falciparum; Mice; Parasitemia; Plasmodium falciparum; Proguanil; Quinolones | 2016 |
Efficacy, safety and tolerance of imidocarb dipropionate versus atovaquone or buparvaquone plus azithromycin used to treat sick dogs naturally infected with the Babesia microti-like piroplasm.
Topics: Animals; Antiprotozoal Agents; Atovaquone; Azithromycin; Babesia microti; Babesiosis; Dog Diseases; Dogs; Drug Therapy, Combination; Europe; Female; Imidocarb; Male; Naphthoquinones; Parasitemia; Polymerase Chain Reaction | 2017 |
In vitro and in vivo properties of ellagic acid in malaria treatment.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Atovaquone; Chloroquine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ellagic Acid; Erythrocytes; Female; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Mice; Mice, Inbred Strains; Molecular Structure; Molecular Weight; Parasitemia; Parasitic Sensitivity Tests; Plasmodium; Plasmodium falciparum; Schizonts; Trophozoites | 2009 |
Mutations in the Plasmodium falciparum cytochrome b gene are associated with delayed parasite recrudescence in malaria patients treated with atovaquone-proguanil.
Topics: Adult; Animals; Antimalarials; Atovaquone; Child, Preschool; Cytochromes b; DNA, Protozoan; Drug Combinations; Drug Therapy, Combination; Female; Genotype; Humans; Malaria, Falciparum; Male; Middle Aged; Mutation; Parasitemia; Plasmodium falciparum; Polymerase Chain Reaction; Proguanil; Recurrence; Time Factors; Treatment Failure | 2008 |
Plasmodium relictum (lineage P-SGS1): Further observation of effects on experimentally infected passeriform birds, with remarks on treatment with Malarone.
Topics: Animals; Antimalarials; Atovaquone; Disease Susceptibility; Drug Combinations; Finches; Hematocrit; Malaria, Avian; Male; Parasitemia; Plasmodium; Proguanil; Species Specificity; Virulence | 2009 |
Emergence of resistance to azithromycin-atovaquone in immunocompromised patients with Babesia microti infection.
Topics: Aged, 80 and over; Animals; Antiprotozoal Agents; Atovaquone; Azithromycin; Babesia microti; Babesiosis; Drug Resistance; Drug Therapy, Combination; Female; Humans; Immunocompromised Host; Male; Middle Aged; Parasitemia | 2010 |
[Post-malaria neurological syndrome complicating a relapse of Plasmodium falciparum malaria after atovaquone-proguanil treatment].
Topics: Antimalarials; Atovaquone; Cerebrospinal Fluid; Cognition Disorders; Confusion; Diagnosis, Differential; Drug Therapy, Combination; Encephalitis, Herpes Simplex; Hepatitis; Humans; Lymphocyte Count; Malaria, Cerebral; Malaria, Falciparum; Male; Meningitis, Aseptic; Middle Aged; Parasitemia; Proguanil; Recurrence; Syndrome | 2011 |
Persistent babesiosis in a stem cell transplant recipient.
Topics: Animals; Anti-Bacterial Agents; Antimalarials; Atovaquone; Azithromycin; Babesia; Babesiosis; Drug Resistance; Drug Therapy, Combination; Humans; Immunocompromised Host; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Parasitemia; Stem Cell Transplantation | 2011 |
Parasitostatic effect of maslinic acid. I. Growth arrest of Plasmodium falciparum intraerythrocytic stages.
Topics: Antimalarials; Atovaquone; Chloroquine; Erythrocytes; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Triterpenes | 2011 |
Variation among Plasmodium falciparum strains in their reliance on mitochondrial electron transport chain function.
Topics: Antimalarials; Atovaquone; Cells, Cultured; Dihydroorotate Dehydrogenase; Drug Resistance; Electron Transport; Fungal Proteins; Humans; Mitochondria; Organisms, Genetically Modified; Oxidoreductases Acting on CH-CH Group Donors; Parasitemia; Plasmodium falciparum; Recombinant Proteins; Ubiquinone | 2011 |
Field evaluation of rapid diagnostic tests for malaria in Yaounde, Cameroon.
Topics: Adult; Antigens, Protozoan; Atovaquone; Cameroon; Child, Preschool; Drug Combinations; Follow-Up Studies; Humans; Infant; L-Lactate Dehydrogenase; Likelihood Functions; Malaria; Parasite Load; Parasitemia; Plasmodium; Predictive Value of Tests; Proguanil; Protozoan Proteins; Reagent Kits, Diagnostic; Reproducibility of Results; Sensitivity and Specificity; Time Factors; Treatment Outcome | 2013 |
Atovaquone-proguanil for recrudescent Plasmodium falciparum in Vietnam.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemisinins; Artesunate; Atovaquone; Child; Disease Outbreaks; Drug Combinations; Drug Resistance, Multiple; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Naphthoquinones; Parasitemia; Plasmodium falciparum; Proguanil; Recurrence; Sesquiterpenes; Treatment Failure; Vietnam | 2003 |
Drug-induced death of the asexual blood stages of Plasmodium falciparum occurs without typical signs of apoptosis.
Topics: Animals; Antimalarials; Apoptosis; Atovaquone; Cells, Cultured; Chloroquine; DNA Fragmentation; DNA, Protozoan; Enzyme Inhibitors; Erythrocytes; Etoposide; Flow Cytometry; Humans; In Situ Nick-End Labeling; Malaria, Falciparum; Membrane Potentials; Mitochondrial Membranes; Naphthoquinones; Nitric Oxide Donors; Parasitemia; Penicillamine; Plasmodium falciparum | 2006 |
In vitro and in vivo interaction of synthetic peroxide RBx11160 (OZ277) with piperaquine in Plasmodium models.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Atovaquone; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Erythrocytes; Female; Heterocyclic Compounds, 1-Ring; Humans; Malaria; Mice; Parasitemia; Parasitic Sensitivity Tests; Peroxides; Plasmodium berghei; Plasmodium falciparum; Pyrimethamine; Quinolines; Spiro Compounds | 2007 |
Clinical efficacy of antiparasite treatments against intestinal helminths and haematic protozoa in Gallotia caesaris (lizards).
Topics: Animals; Antiparasitic Agents; Atovaquone; Chloroquine; Drug Combinations; Feces; Fenbendazole; Helminthiasis, Animal; Intestinal Diseases, Parasitic; Lizards; Parasitemia; Pilot Projects; Proguanil; Protozoan Infections, Animal | 2007 |
Babesia gibsoni: detection during experimental infections and after combined atovaquone and azithromycin therapy.
Topics: Acute Disease; Animals; Anti-Infective Agents; Antibodies, Protozoan; Atovaquone; Azithromycin; Babesia; Babesiosis; Chronic Disease; DNA, Protozoan; Dog Diseases; Dogs; Drug Resistance; Female; Fluorescent Antibody Technique; Parasitemia; Polymerase Chain Reaction | 2007 |
Selective ambulatory management of Plasmodium falciparum malaria in paediatric refugees.
Topics: Adolescent; Ambulatory Care; Antimalarials; Atovaquone; Australia; Child; Child, Preschool; Female; Follow-Up Studies; Hospitalization; Humans; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Patient Compliance; Proguanil; Quinine; Refugees | 2007 |
Mutation underlying resistance of Plasmodium berghei to atovaquone in the quinone binding domain 2 (Qo(2)) of the cytochrome b gene.
Topics: Amino Acid Sequence; Animals; Antimalarials; Atovaquone; Benzoquinones; Cytochrome b Group; Drug Resistance; Malaria; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Mutation; Parasitemia; Parasitic Sensitivity Tests; Plasmodium berghei | 2008 |
Atovaquone-proguanil resistance in imported falciparum malaria in a young child.
Topics: Animals; Antimalarials; Atovaquone; Child; Cytochromes c; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Male; Mozambique; Mutation, Missense; North America; Parasitemia; Plasmodium falciparum; Proguanil; Treatment Failure | 2008 |
Successful prevention and treatment of babesiosis with atovaquone.
Topics: Animals; Antiprotozoal Agents; Atovaquone; Babesiosis; Chemoprevention; Cricetinae; Dexamethasone; Evaluation Studies as Topic; Glucocorticoids; Immunosuppression Therapy; Male; Naphthoquinones; Parasitemia; Survival Analysis | 1995 |
Atovaquone in the treatment of Babesia microti infections in hamsters.
Topics: Animals; Anti-Bacterial Agents; Antimalarials; Antiprotozoal Agents; Artemisinins; Atovaquone; Azithromycin; Babesiosis; Cricetinae; Disease Models, Animal; Drug Therapy, Combination; Naphthoquinones; Parasitemia; Recurrence; Sesquiterpenes | 1996 |
Therapeutic efficacy of atovaquone against the bovine intraerythrocytic parasite, Babesia divergens.
Topics: Acute Disease; Animals; Antiprotozoal Agents; Atovaquone; Babesia; Babesiosis; Cattle; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Erythrocytes; Gerbillinae; Hemoglobinuria; Humans; Naphthoquinones; Parasitemia; Regression Analysis | 1997 |
Assessment of the activity of atovaquone-loaded nanocapsules in the treatment of acute and chronic murine toxoplasmosis.
Topics: Acute Disease; Administration, Oral; Animals; Antiprotozoal Agents; Atovaquone; Brain; Capsules; Chronic Disease; Colloids; Disease Models, Animal; Drug Carriers; Drug Stability; Female; Lung; Mice; Naphthoquinones; Parasitemia; Solubility; Survival Rate; Suspensions; Temperature; Toxoplasma; Toxoplasmosis, Animal | 1998 |
Malarone treatment failure and in vitro confirmation of resistance of Plasmodium falciparum isolate from Lagos, Nigeria.
Topics: Amino Acid Substitution; Animals; Antimalarials; Atovaquone; Codon; Cytochromes b; Drug Combinations; Drug Resistance; Humans; London; Malaria, Falciparum; Male; Middle Aged; Mutation, Missense; Naphthoquinones; Nigeria; Parasitemia; Plasmodium falciparum; Proguanil; Protozoan Proteins; Travel | 2002 |